Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant versus sequential CYD dengue vaccine and Adacel in healthy participants in the Philippines
2019-003136-23Phase 3
- Sponsor
- Sanofi
- Start
- Feb 2020
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of acellular pertussis vaccine and CYD dengue vaccine in dengue fever (2 arms), sponsored by Sanofi. Primary endpoint: Humoral immune response to Tdap booster.
02
Drugs
acellular pertussis vaccineCYD dengue vaccine
03
Conditions
dengue fever
Beyond the preview
Go deeper on 2019-003136-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003136-23.